According to the FY 2022 annual report of Sun Pharma, it is ranked number 1 in terms of prescriptions with an 8.34% market share in India. The company has 32 brands among India’s top 300 brands. The company offers drugs in various therapeutic segments such as neuropsychiatry, cardiology, diabetes, gastrointestinal, pain/analgesics, gynaecology, ophthalmology, urology, dermatology, respiratory and anti-infectives.
